Active, Not Recruiting
Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm Study
NCT05602935
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +5 more
- Locations
-
- The Second Affiliated Hospital of Fujian Medical University Fuzhou, Fujian, China